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Quercetin-7-O-rhaminosideAbstract The present study was designed to investigate secondary metabolite contents of
Scorzonera alexandrina growing in the North–Western coast of Egypt. In addition hepatoprotective
activity, reduction in blood sugar and ulcerative colitis were also evaluated . Chromatographic
methods and spectroscopic analysis were used for isolation and identiﬁcation of the compounds.
In the hepatoprotective activity; twenty-four adult male Wistar albino rats were divided into four
groups of six animals each. Rats of the 1st (normal control) and 2nd (CCl4-intoxicated control)
groups received the vehicle in a dose of 5 mL/kg. The 3rd and 4th groups were treated with the ethanol
extract of S. alexandrina in doses of 200 and 400 mg/kg, respectively. In the ulcerative colitis study, the
same extract was administered orally (200 and 400 mg/kg) to rats once a day for 5 consecutive days
and the last dose was administered 2 h before induction of colitis by intra-rectal infusion of acetic acid.
The obtained results revealed that S. alexandrina contains scopoletin, xanthotoxin, apigenin, luteolin,
quercetin-7-O-rhaminoside and luteolin-7-O-glucoside, also it showed a signiﬁcant decrease in blood
glucose level, liver functions (ALT, AST, TP), also a signiﬁcant anti-ulcer effect.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The genus Scorzonera encompasses about 160 species and
being Ancient Mediterranean in origin, it is widely spread in
arid regions of Eurasia and Africa, in Egypt, the genus Scorz-onera is represented by ﬁve species, namely; Scorzonera pseudo-
lanata Grossheim, Scorzonera mollis Bieb, Scorzonera
schweinfurthii Boiss, Scorzonera drarii Tackh and Scorzonera
alexanderina Boiss. The ﬁrst four species are very rare in the
Egyptian deserts while the last species is very common and en-
demic to the North–Western Coastal strip of Egypt. S. alex-
anderina is a small perennial herbaceous plant with tuberous
edible root. The ﬂowers are pale mauve, deep purple at the
center emitting a nice scent of vanilla. It appears only on rainy
seasons (Ta¨ckholm, 1974).
Previous chemical investigations of this genus yielded dihy-
dro-isocoumarins, ﬂavonoids, lignans, phenolic acids, sesqui-
terpene, sesquiterpene lactone, triterpenes and a new class of
bibenzyl derivatives (Zidorn et al., 2003; San et al., 2007). In
addition to utilizing the fresh leaves as an ingredient in green
S434 A. M. Doniasalad, its sub aerial parts are considered to be a potent tonic
and continue to be used in traditional medicine as analgesic,
antirheumatic, anthelmintic, curing fever, carbuncle, mastitis
and treatment of fertility, also it is used as a diabetic diet for
containing inulin and laevulin (Baytop, 1984).
A new friedoolean-type triterpene, 3b-acetoxyglutin-5(10)-
en-6-oxo, together with seventeen known compounds were iso-
lated from the roots of Scorzonera austriaca (Wu et al., 2011).
Extracts prepared from the aerial parts of Scorzonera cana
var. jacquiniana, Scorzonera cana cinerea, Scorzonera cana erio-
phora, Scorzonera cana incisa and Scorzonera cana parviﬂora
showed a signiﬁcant inhibitory effect on carrageenan and
PGE2-induced hind paw edemamodel as well as on p-benzoqui-
none-induced abdominal constriction test (Akkol et al., 2012).
No phytochemical and biological studies have been re-
ported for S. alexandrina. Therefore, the present study was de-
signed to investigate the phytochemical and biological
activities of this plant.
2. Material and methods
2.1. Plant material
S. alexandrina was collected in the wild form from the North–
Western coast of Egypt during spring (2010) and a voucher
specimen has been deposited in the herbarium of the Desert
Research Center, Cairo-Egypt. The collected plant was dried
under shade and then grinded to ﬁne powder.
2.2. Extraction and isolation
About 500 g of the air dried powder of S. alexandrina (aerial
and sub aerial parts) were extracted by aqueous ethanol. The
combined ethanolic extracts were concentrated under reduced
pressure at a temperature not exceeding 35 C. The ethanolic
extract of S. alexandrina (25 g) was separated into fractions
on a silica gel (500 g) column and eluted with Chloroform
(fractions 1–12), after that Chloroform–methanol (fractions
13–45). Fractions 1–12 (1.8 g) were reapplied to a silica gel col-
umn eluted with chloroform, from which compounds 1 and 2
were isolated. Fractions 13–45 (6.5 g) were reapplied to a sec-
ond silica gel column and eluted with chloroform:methanol
from this column, compounds 3, 4, 5 and 6 were isolated.
2.3. Pharmacological studies
2.3.1. Experimental animals
Male Wistar albino rats (220–240 g) and albino mice of both
sexes (25–28 g) were maintained in the Laboratory Animal Unit
of the College of Pharmacy, Salman Bin Abdulaziz University.
They were housed in polypropylene cages and fed with standard
chow diet and water ad libitum. Animals were allowed to adapt
to the laboratory environment for one week before experimen-
tation. The care and handling of the animals were in accordance
with the internationally accepted standard guidelines. All ani-
mal procedures were approved by an institutional review board
of Pharmacy College, Salman Bin Abdulaziz University, KSA.
2.3.2. Acute toxicity experiment
Albino mice were divided into control and test groups (6 ani-
mals each). Control group received the vehicle (3% Tween 80)while the test groups got graded doses (1000–4000 mg/kg) of S.
alexandrina ethanol extract orally and were observed for mor-
tality till 48 h and the LD50 was calculated (Ghosh, 1994).
2.3.3. Effect of prolonged administration
Eighteen male Wistar albino rats were randomly divided into 3
groups of 6 animals. The 1st group was kept as control (5 mL/
kg of 3% Tween 80), while 2nd and 3rd groups were adminis-
tered the ethanol extract of S. alexandrina in doses of 200 and
400 mg/kg, respectively. All medications were administered or-
ally with the aid of an orogastric cannula for 35 consecutive
days. Rats were maintained under identical conditions with
food and water ad libitum for the entire period with close
observation. At the end of the experimental period, blood sam-
ples (2 mL) were drawn by puncturing retro-orbital venous si-
nus of each rat (under ether anesthesia) and centrifuged at
10,000 rpm for 5 min. Sera were separated to be used for the
biochemical estimations.
2.3.4. Experimental induction of hepatic damage
CCl4 was dissolved in corn oil in the ratio 1:1 v/v. Liver dam-
age was induced in rats following subcutaneous (SC) injection
of CCl4 in the lower abdomen at a dose of 3 mL/kg (Theophile
et al., 2006).
2.3.5. Hepatoprotective activity
Twenty-four adult male Wistar albino rats were randomly di-
vided into four groups of six animals each. Rats of the 1st
(normal control) and 2nd (CCl4-intoxicated control) groups re-
ceived the vehicle in a dose of 5 mL/kg. The 3rd and 4th
groups were treated with the ethanol extract of S. alexandrina
in doses of 200 and 400 mg/kg, respectively. All medications
were administered orally by gastric intubation for 7 consecu-
tive days. Two h after the last dose, normal control rats were
given a single dose of corn oil (3 mL/kg, SC), while animals
of the 2nd–4th groups received a single dose of CCl4 (3 mL/
kg, SC).
2.3.6. Measurement of liver and kidney function markers
Liver functions were evaluated by measuring the serum activity
of alanine transaminase (ALT) and aspartate transaminase
(AST), following the method of Reitman and Frankel (1957).
The serum concentrations of total bilirubin (TB) (Walter and
Gerarade, 1970), total protein (TP) (Henary et al., 1974) and
albumin (Alb) (Doumas et al., 1971) were estimated. Serum
levels of urea (Wills and Savory, 1981) and creatinine (Kroll
et al., 1987) were determined colorimetrically as measures of
kidney functions.
2.3.7. Measurement of blood glucose level
Determination of the blood glucose level was done by the glu-
cose-oxidase principle (Rheney and Kirk, 2000), results were
reported as mg/dl.
2.3.8. Effect on ulcerative colitis
The total ethanolic extract of S. alexandrina and the standard;
dexamethasone (DEX) was suspended separately in 3% v/v
Tween 80 (vehicle).
Thirty male Wistar albino rats were divided into 5 equal
groups. Groups 1 and 2 (normal and colitis control groups,
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Group 3 (reference group) was given DEX in a dose of
0.2 mg/kg. Groups 4 and 5 were administered the ethanolic ex-
tract of S. alexandrina in doses of 200 and 400 mg/kg, respec-
tively. All medications were administered orally via the aid of
an orogastric cannula, once a day for 5 consecutive days and
the last dose was administered 2 h before colitis induction.
2.3.9. Induction of ulcerative colitis
Rats were fasted for 24 h with access to water ad libitum after
which they were lightly anesthetized with ether. A polyethylene
catheter with 2 mm diameter was inserted through the rectum
into the colon to a distance of 8 cm (Ghaneya and Soliman,
2010). For Ulcerative colitis induction, 2 mL of 4% (v/v) acetic
acid was infused into the colon of all rats (except the normal
control group) through the catheter, held in place for 30 s,
and then ﬂushed with 5 mL of phosphate buffer solution;
pH = 7. The catheter was left in place for few seconds then
gently removed.
2.3.10. Assessment of colonic lesions
Two days after the induction of colitis, each rat was inspected
and diarrhea was recorded. Rats were sacriﬁced using ether
anesthesia and colonic segments (8 cm in length and 3 cm prox-
imal to the anus) were excised, opened along its mesenteric bor-
der, and rinsed thoroughly in ice-cold normal saline. The colon
specimen of each rat was weighed and the wet weight/length ra-
tio was calculated as ratio of the colon specimen weight vs. its
length (mg/cm). It was used as a parameter to assess the degree
of colon edema, which reﬂected the severity of colitis. The spec-
imens were examined under a dissecting microscope and all vis-
ible damages were evaluated using the scoring system reported
by Morris et al. (1989) with some modiﬁcations. The lesion
scores were: 0 = no damage, 1 = local edema and inﬂamma-
tion without ulcers; 2 = one ulcer without inﬂammation;
3 = one to two ulcers with inﬂammation and lesion diameter
<1 cm; 4 =More than two ulcers with lesion diameter 1–
2 cm; 5 = Severe ulceration with lesion diameter >2 cm. Ulcer
area was measured for each specimen using a 1 mm2 grid.Ulcer
index was measured by summing the lesion score and the ulcer
area for each colon specimen (Minaiyan et al., 2006).
3. Statistical analysis
The values are expressed as mean ± standard error of six
observations in each group. All groups were subjected to
one-way analysis of variance (ANOVA), which was followed
by Bonferoni’s test to determine the intergroup variability by
using SPSS ver. 14.Table 1 Effect of prolonged oral administration of ethanolic extrac
AST and serum levels of total bilirubin, total protein, albumin and
Groups Doses (mg/kg) ALT (U L1) AST (U L1) T. bilirubin
Control 00 66.50 ± 3.56 139.38 ± 6.44 1.51 ± 0.10
S. alexandrina 200 63.50 ± 1.50 135.38 ± 5.41 1.51 ± 0.2
400 61.70 ± 3.82* 134.27 ± 6.80 1.53 ± 0.11*
* Signiﬁcance (p< 0.05).
** Signiﬁcance (p< 0.01).4. Results
4.1. Toxicological Studies
S. alexandrina in oral doses up to 4000 mg/kg b. wt. did not
produce any demonstrable acute toxic effects or deaths in all
groups of animals.
4.2. Effect of prolonged administration
From the data presented in Table 1 it can be concluded that S.
alexandrina showed a reduction in blood glucose after pro-
longed administration in both doses 200 and 400 mg/kg, also
the same trend at 400 mg/kg was achieved in ALT
(61.70 ± 3.82 U L1), T. Bilirubin (1.53 ± 0.11 mg d L1)
and T. Protein (8.5 ± 0.38 mg d L1).
4.3. Hepatoprotective activity
S. alexandrina showed signiﬁcant effects on liver function tests
Table 2 which appeared as a reduction of all studied parame-
ters at dose of 400 mg/kg, also a signiﬁcant decrease in blood
glucose (188.5 ± 7.11 mg d L1 vs. 221.7 ± 9.06 mg d L1 of
CCl4-intoxicated Control) was observed in CCl4 induced-
hepatotoxicity experiment.
4.4. Anti-ulcerogenic effect
Experimental colitis was accompanied by marked anorexia,
prostration, hypomotility and pilorection after acetic acid
challenge (data not shown). Diarrhea, as evidenced indirectly
by perianal fur soiling, was prominent among colitic animals.
The incidence of diarrhea, lesion score, ulcer area and ulcer in-
dex were used as the indicators for the effectiveness of the
tested extracts against colitis induced by acetic acid in rats.
The intestinal damage induced by acetic acid was associated
with a signiﬁcant increase of wet weight/length ratio of the co-
lon specimens as an indicator of inﬂammation. The wet
weight/length ratio increased 3-fold in rats with acetic acid
colitis compared to normal rats (0.97 ± 0.04 vs.
0.30 ± 0.02 g/cm). This ratio was greatly improved in rats that
pre-medicated with 0.2 mg/kg of DEX (0.36 ± 0.02 g/cm) and
400 mg/kg of the ethanolic extracts of S. alexandrina
(0.42 ± 0.01 g/cm). Morphologically, a thickened wall and
brown to black lesions were observed in the injured colon spec-
imens of control colitis rats, 2 days after rectal infusion of ace-
tic acid. Under dissecting microscope, hyperemia, edema,
erosion, and severe ulceration were also observed. Controlt of S. alexandrina for 35 days on the serum activity of ALT and
glucose in rats, (n= 6).
(mg d l1) T. protein (g d l1) Albumin (g d l1) Glucose (mg d l1)
8.0 ± 0.34 3.5 ± 0.17 115.83 ± 5.84
8.2 ± 0.30 3.4 ± 0.12 109.83 ± 4.94*
8.5 ± 0.38* 3.4 ± 0.12 88.63 ± 4.75**
Table 3 Effects of oral administration of ethanolic extract of S. alexindrina on the macroscopic parameters of ulcerative colitis
induced by acetic acid in rats (n= 6).
Groups Doses (mg/kg) Lesion score (0–5) Ulcer area (cm2) Ulcer index Wet W/L ratio (g/cm)
Sham (Normal control) 00 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.30 ± 0.02
Colitis control 00 3.9 ± 0.20 5.0 ± 0.23 8.9 ± 0.25 0.97 ± 0.04
DEX 0.2 2.1 ± 0.15*** 2.2 ± 0.18*** 4.3 ± 0.25*** 0.36 ± 0.02***
S. alexindrina 200 3.7 ± 0.18 4.7 ± 0.24* 8.4 ± 0.33 0.68 ± 0.03*
400 3.5 ± 0.18* 4.1 ± 0.21* 7.6 ± 0.31* 0.42 ± 0.01**
* Signiﬁcance (p< 0.05).
** Signiﬁcance (p< 0.01).
*** Signiﬁcance (p< 0.001).
Table 2 Effect of the ethanolic extract of S. alexandrina on the serum activity of ALT and AST and serum levels of total bilirubin,
total protein, albumin and glucose in rats with CCl4 induced-hepatotoxicity.
Groups ALT (U L1) AST (U L1) T. bilirubin
(mg d l1)
T. protein
(g d l1)
Albumin
(g d l1)
Glucose
(mg d l1)
Normal control 68.0 ± 2.11* 140.5 ± 4.18* 1.24 ± 0.06* 8.47 ± 0.39* 3.65 ± 0.18* 115.83 ± 5.84*
CCl4-intoxicated control 372.5 ± 11.9 434.6 ± 13.4 3.3 ± 0.11 5.7 ± 0.19 2.1 ± 0.14 221.7 ± 9.06
S. alexandrina (200 mg/kg) + CCl4 360.7 ± 9.7 419.2 ± 11.6 3.4 ± 0.14 5.8 ± 0.17 2.16 ± 0.12 214.5 ± 8.20
S. alexandrina (400 mg/kg) + CCl4 311.7 ± 9.3
* 377.2 ± 13.9** 3.8 ± 0.15* 6.1 ± 0.13* 2.6 ± 0.13* 188.5 ± 7.11*
* Signiﬁcance compared to CCl4 group (p< 0.05).
** Signiﬁcance (p< 0.01).
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ues of 3.9 ± 0.20, 5.0 ± 0.23 cm2 and 8.9 ± 0.25, respectively
(Table 3). These inﬂammatory indices were signiﬁcantly im-
proved by oral dosing of DEX and ethanolic extracts of S.
alexandrina (200 and 400 mg/kg) for 5 days prior to ulcer
induction.
4.5. Phytochemical Studies
4.5.1. Isolated compounds
Compound (1): White crystals, 1H NMR (500 MHz, CDCl3) d
7.90 (1H, d, J= 12.5, H-4), d 7.24 (1H, s, H-5), d 6.72 (1H, s,
H-8), d 6.24 (1H, d, J= 10.5, H-3) and d 3.77 (3H, s, OCH3).
13C–NMR (125 MHz, CDCl3): d 160.78 (C-2), 152.0 (C-7),
149.22 (C-9), 145.41 (C-6), 144.1 (C-4), 111.7 (C-3), 110.3
(C-10), 109.7 (C-5), 102.28 (C-8), 56.18 (–OCH3).
Compound (2): Obtained as needle crystals, 1H-NMR
(500 MHz, CDCl3): d 7.8 (1H, d, J= 9 Hz, H-4); 7.62 (1H,
d, J= 2.5 Hz, H-50). d 7.35 (1H, S, H-5), d 7.1 (1H, d,
J= 2.5 Hz, H-40); d 6.38 (1H, d, J= 9.5 Hz, H-3). 13C-
NMR (125 MHz, CDCl3): 161.36 (C-2), 147.73 (C-7), 147.19
(C-20), 145.32 (C-40), 142.77 (C-4), 126.66 (C-6), 116.71 (C-5),
113.66 (C-3), 113.76 (C-50, 106.62 (C-30), 60.44 (C-8).
Compound (3): Yellow powder; 1H-NMR (500 MHz,
CD3OD): d 7.46 (1H, dd, J= 8, 2.3 Hz, H-60), 7.42 (1H, d,
J= 2.4 Hz, H-20), 6.90 (1H, d, J= 8.2 Hz, H-50), 6.67 (1H,
s, H-3),), 6.45 (1H, d, J= 2.1 Hz, H-6), 6.20 (1H, d,
J= 2.1 Hz, H-8. 13C NMR (125 MHz, CD3OD): d 182.0
(C-4), 164.5 (C-5), 164.3 (C-2), 161.9 (C-7), 157.7 (C-9),
150.1 (C-40), 146.1 (C-30), 121.9 (C-10), 119.3 (C-60), 116.4 (C-
50), 113.8 (C-20), 104.1 (C-10), 103.2 (C-3), 99.2 (C-6), 94.3
(C-8),Compound (4): Yellow powder; (500 MHz, CD3OD): d 6.19
(1H, d, J= 2.1 Hz, H-8), 6.47 (1H, d, J= 2.1 Hz, H-6), 6.76
(1H, s, H-3), 6.92 (2H, d, J= 9.7 Hz, H-20 and H-60), 7.92
(2H, d, J = 9.7 Hz, H-30 and H-50). 13C NMR (125 MHz,
CD3OD): d 182.1 (C-4), 164.5 (C-7), 164.1 (C-10), 161.5 (C-
40), 161.8 (C-9), 157.7 (C-5), 128.8 (C-3 and C-50), 121.6 (C-
2), 116.3 (C-20 and C-60), 104.1 (C-10), 103.2 (C-3), 99.2 (C-
6) 94.3 (C-8).
Compound (5): yellow crystal, 1H NMR (CD3OD): d 7.4
(1H d, J= 2 Hz H-20), 7.3 (1H dd, J= 8.5 J= 2.1 Hz H-
60), 6.8 (1H d, J= 8.5 Hz H-50), 6.4 (1H d, J= 2.5 Hz H-8),
6.2 (1H d, J= 2.5 Hz H-6), 5.2 (1H d, J= 2.5 Hz H-1 rham-
nose), 1.2 (3H d, J= 6 Hz CH3), sugar protons at d 3.2–3.9.
13C NMR (CD3OD) d 178.9 (C-4), 163.20 (C-7), 159 (C-5),
155.20 (C-9), 149 (C-2), 146.70 (C-40), 144.80 (C-30), 134.80
(C-3), 121.30 (C-10), 119.70 (C-60), 115.60 (C-50), 114.80 (C-
20), 103.20.(C-10), 100.70 (C-100 sugar), 99.80 (C-6), 92.50 (C-
8), 75.20 (C-500), 70.60(C-400), 70 30 (C-300), 68.10 (C-200) and
17.60 (–CH3).
Compound (6): Yellow powder; 1H-NMR (500 MHz,
DMSO-d6): d 7.43 (1H, s, H-20), 7.41 (1H, d, J= 8.0 Hz, H-
60), 6.93 (1H, d, J = 8.0 Hz, H-50), 6.83 (1H, d, J= 1.8 Hz,
H-8), 6.64 (1H, s, H-3), 6.44 (1H, d, J= 1.8 Hz, H-6), 5.10
(1H, d, J= 7.8 Hz, H100), 3.85 (1H, dd, J = 12.2, 1.8 Hz,
H600), 3.68–3.60 (1H, m, H500), 3.56 (1H, t, J= 9.0 Hz, H300),
3.49 (1H, t, J= 9.0 Hz, H300), 3.41 (1H, t, J= 9.0 Hz, H400).
13C-NMR (125 MHz, DMSO-d6): d 182.6 (C-4), 165.65 (C-
7). 147.1(C-30), 120.6 (C-10), 116.9 (C-50), 113.5 (C-20),
163.88 (C-2), 161.44 (C-5), 157.78 (C-9), 152.5 (C-40), 120.2
(C-60), 106.0 (C-10), 103.2 (C-3), 100.6 (C1), 100.21 (C-6),
95.7 (C-8), 77.5 (C300), 76.66 (C500),73.4 (C200), 70.2 (C400),
61.2 (C600).
 Scopoletin              Xanthtoxin  
Compound R1 R2 R3
Apegenin H OH H
Luteolin H OH OH
Luteolin-7-O-glucoside H O-glucoside OH
Quercetin-7-O-rhamnoside OH O-rhamnoside OH
Figure 1 Isolated compounds from S. alexandrina.
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5.1. Effect of prolonged administration
From the data presented in Table 1 it can be concluded that S.
alexandrina showed reduction in blood glucose after prolonged
administration in both doses 200 and 400 mg/kg, also the same
trend at 400 mg/kg was achieved in ALT (61.70 ± 3.82 U L1)
also T. Bilirubin (1.53 ± 0.11 mg d l1) and T. Protein
(8.5 ± 0.38 g d l1). These are in the same trend with the pre-
vious review (Baytop, 1984), and no signiﬁcant effects were ob-
served in urea and creatinine levels . Urea and creatinine are
the most sensitive biochemical markers employed in the diag-
nosis of renal damage. In kidney damage, there will be reten-
tion of urea and creatinine in the blood (Nwanjo et al.,
2005), therefore a marked increase in serum urea and creati-
nine is indications of functional damage to the kidney (Panda,
1999). By these indicators, ethanol extract of S. alexandrina is
therefore, not nephrotoxic in rats.5.2. Hepatoprotective activity
Livermarker enzymes are localized in the cytosol of hepatic cells
and thus are extruded into the serum when cells are damaged or
necrotic. In this study, rats intoxicated with CCl4 developed sig-
niﬁcant hepatic damage asmanifested by a signiﬁcant increase in
the serumactivities ofALT andAST that are indicators of hepa-
tocyte damage and loss of functional integrity. Pretreatment of
rats with the ethanol extract of S. alexandrina in dose of
400 mg/kg effectively protected rats against CCl4-induced hepa-
tic damage, resulting in reduction in serumactivities of livermar-
ker enzymes when compared to the intoxicated control rats.
Decrease in the level of these enzymes with S. alexandrina is an
indication of the stabilization of plasma membrane as well as
the repair of liver damage caused by CCl4.
Further, the rise in the level of TB in serum following CCl4
intoxication is also a measure of hepatotoxicity and could beattributed to impaired hepatic clearance due to hepatic paren-
chymal damage and biliary obstruction (Blanckaert and Sch-
mid, 1982). The ability of the ethanol extract of S.
alexandrina (400 mg/kg) to reduce the level of TB in the serum
of intoxicated rats suggests its potential hepatoprotective ef-
fect. The lowered serum levels of TP and Alb due to CCl4-
intoxication is attributed to the initial damage of the endoplas-
mic reticulum which results in the loss of P-450 leading to fatty
liver (Recknage, 1967). Administration of the ethanol extract
of S. alexandrina in dose of 400 mg/kg remarkably prevented
CCl4-induced reduction of TP and Alb in serum. This assures
the hepatoprotective activity of this extract against damage by
CCl4. This activity may be attributed to ﬂavonoidal contents
of this plant. In this trend Jin et al. (2011) reported the ﬂavo-
noid rich extract of Salvia plebeian and its striking beneﬁcial
effects in preventing carbon tetrachloride induced cute hepatic
injury in mice. The contents of Salvia plebeian were mainly
ﬂavonoids which have been identiﬁed as hispidulin, homoplan-
taginin, nepetin, luteolin luteolin-7-glucoside and nepetin-
7glucoside.
5.3. Anti-ulcerogenic effect
The present study demonstrated that treatment of rats with the
ethanolic extract of S. alexandrina (200 and 400 mg/kg) re-
duced the inﬂammation and the acute colonic damage induced
by acetic acid. The protective effect against acetic acid induced
ulcers could be attributed to the phenolic and/or ﬂavonoid
content of the tested plant and their reactive oxygen species
scavenging property. These results are in agreement with that
of Akkol et al. (2011) who revealed that, methanol–water ex-
tracts from aerial parts of Scorzonera latifolia and S. mollis
were found to have wound healing and anti-inﬂammatory
activities compared to control groups. This might be due to
the combined effect of the constituents present in the studied
plant; the highest anti-inﬂammatory activity was seen on the
extract of S. latifolia, which has the highest amount of hypero-
side. Luteolin-7-O-glucoside was found to possess anti-inﬂam-
S438 A. M. Doniamatory activity (Akdemir et al., 2011). Therefore, anti-ulcero-
genic effect (anti-inﬂammatory) potential of S. alexandrina
may be attributed to the phytoconstituents (Luteolin and lute-
olin-7-O-glucoside) present in this plant, which may be either
due to their individual or additive effect that speeds up the
process.
5.4. Phytochemical studies
5.4.1. Isolated compounds
Compounds 1 and 2 (Fig. 1) were isolated from chloroform
fractions. They were identiﬁed as scopoletin and xanthotoxin
by comparing their TLC chromatograms, 1H NMR and 13C
NMR spectra with reference samples and published data
(Khamis et al., 1999; Murray et al., 1982).
From the present and published data (Lin and Harnly,
2010; Lee et al., 2013) compound 3 was identiﬁed as Luteolin.
Compound 4 was identiﬁed as apigenin (Lin and Harnly,
2010; Lee et al., 2013)
Acid hydrolysis (Harborne et al., 1975) of compound 5 re-
vealed the sugar rhamnose, which was identiﬁed by TLC (ethyl
acetate–methanol–acetic acid–water (65:15:10:10). The agly-
cone was identiﬁed based on comparison by TLC and UV shift
reagents. Compound 5 was substituted at position 7 as indi-
cated by their UV spectra. From these data and published data
(Mabry et al., 1970) identiﬁed these compounds as quercetin 7-
O-rhamnoside.
Acid hydrolysis of compound 6 revealed that the glycone
moiety was glucose, which was identiﬁed by TLC (ethyl ace-
tate–methanol–acetic acid–water (65:15:10:10). The aglycone
was identiﬁed based on comparison by TLC and UV shift re-
agents and it was identical with compound 3.
From given and published data (Lee et al., 2013) compound
6 was identiﬁed as Luteolin-7-O-glucoside.
6. Conclusion
In the present study, it has been observed that S. alexandrina
offered six compounds namely, Scopoletin, xanthtoxin, apege-
nin, luteolin, luteolin-7-O-glucoside, quercetin-7-O-glucoside
also this plant showed hepatoprotective and anti-ulcerogenic
activities, which were mainly due to the ﬂavonoid contents
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